Clinicians typically identify peri-lead edema after DBS as a delayed complication occurring one to two weeks post-surgery. However, recent observations present a rare scenario where a patient developed immediate symptoms. A 71-year-old woman underwent bilateral ventral intermediate nucleus (VIM) deep brain stimulation for medically refractory essential tremor. Immediately following the procedure, she experienced complete anarthria. This case highlights the need for vigilance regarding early inflammatory responses in neural tissue. Furthermore, it challenges the traditional timeline for postoperative edema.

Managing Acute Peri-lead Edema after DBS

Early postoperative imaging is critical when patients present with unexpected neurological deficits. In this case, initial CT scans showed correct lead placement without signs of hemorrhage. Consequently, follow-up imaging on days 2 and 5 revealed progressive edema. Subsequent MRI at day 8 confirmed T2-hyperintense signal alterations around the leads. Additionally, the surgical team initiated corticosteroid therapy to mitigate the inflammatory response. This management led to a gradual recovery of speech over three weeks. Therefore, clinicians must distinguish this condition from vascular complications like stroke or hemorrhage.

Notably, the patient achieved favorable tremor control at her four-month follow-up. While she had residual moderate dysarthria and ataxia, the primary motor symptoms were significantly reduced. This outcome suggests that early peri-lead edema does not necessarily preclude therapeutic success. Specifically, optimized medical management with steroids can resolve acute deficits. In contrast to permanent surgical trauma, inflammatory edema typically follows a favorable course when identified promptly.

Postoperative Monitoring and Lessons

Surgeons should monitor for confusion, seizures, and speech changes immediately after lead implantation. Although symptomatic edema is rare, occurring in roughly 3% of cases, its acute presentation mimics severe vascular events. High-dose dexamethasone or prednisone often serves as the first-line treatment. Clinical teams must ensure that stimulation parameters remain conservative during the acute recovery phase. Ultimately, this illustrative case reinforces that even severe presentations like anarthria can resolve with appropriate intervention.

Frequently Asked Questions

How common is peri-lead edema after DBS?

While many patients show mild, asymptomatic edema on postoperative scans, symptomatic peri-lead edema occurs in approximately 2-4% of patients. It typically appears 7 to 14 days after surgery but can occur acutely.

Can peri-lead edema be confused with a stroke?

Yes, the sudden onset of focal neurological deficits, such as anarthria or hemiparesis, can mimic a vascular event. Clinicians must use MRI or CT to rule out hemorrhage and confirm the presence of edema.

What is the standard treatment for symptomatic edema?

The standard management involves a tapering course of corticosteroids, such as dexamethasone. This treatment reduces inflammation and mass effect around the stimulation leads, often leading to full symptom resolution.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.

References

1. Nickl R et al. Acute postoperative anarthria following bilateral ventral intermediate nucleus deep brain stimulation: a rare presentation of early peri-lead edema. Illustrative case. J Neurosurg Case Lessons. 2026 May 11. doi: undefined. PMID: 42114167.

2. Holewijn RA, et al. Symptomatic Peri-lead Edema after Deep Brain Stimulation. Stereotact Funct Neurosurg. 2021;99(4):328-335.

3. Nevrlý M, et al. Deep brain stimulation peri-lead edema: Common or uncommon complication? Mov Disord. 2020; 35 (suppl 1).